PF-Atlas › Clinical Trials › NCT05331300

A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease

LASN01 · Phase 1

Registry ID

NCT05331300

Phase

Phase 1

Status

Completed

Drug / intervention

LASN01

Sponsor

Lassen Therapeutics 1 PTY LTD

Start

2022-06-06

About this trial

LASN01 is evaluated in NCT05331300, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Lassen Therapeutics 1 PTY LTD. Current status: Completed.

View NCT05331300 on ClinicalTrials.gov →

Explore related

All LASN01 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT05331300 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.